Direxion Daily LLY Bull 2X ETF (NASDAQ:ELIL) Short Interest Up 121.1% in August

Direxion Daily LLY Bull 2X ETF (NASDAQ:ELIL) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 68,316 shares, a growth of 121.1% from the August 15th total of 30,896 shares. Based on an average daily volume of 75,575 shares, the days-to-cover ratio is currently 0.9 days. Currently, 10.0% of the company’s shares are sold short.

Direxion Daily LLY Bull 2X ETF Stock Performance

Shares of Direxion Daily LLY Bull 2X ETF stock traded up $1.10 during trading on Monday, hitting $26.99. The stock had a trading volume of 29,505 shares, compared to its average volume of 113,512. The stock has a 50 day simple moving average of $29.71 and a 200 day simple moving average of $25.53. Direxion Daily LLY Bull 2X ETF has a 1 year low of $14.58 and a 1 year high of $35.13.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. IMC Chicago LLC acquired a new position in Direxion Daily LLY Bull 2X ETF in the 1st quarter valued at approximately $250,000. Susquehanna International Group LLP boosted its stake in shares of Direxion Daily LLY Bull 2X ETF by 148.0% during the 3rd quarter. Susquehanna International Group LLP now owns 38,520 shares of the company’s stock worth $641,000 after acquiring an additional 22,987 shares in the last quarter. Virtu Financial LLC acquired a new position in Direxion Daily LLY Bull 2X ETF during the third quarter valued at approximately $934,000. Finally, Goldman Sachs Group Inc. acquired a new position in Direxion Daily LLY Bull 2X ETF in the 1st quarter valued at $585,000.

Direxion Daily LLY Bull 2X ETF Company Profile

Direxion Shares ETF Trust – Direxion Daily LLY Bull 2X Shares is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund uses derivatives such as swaps and options to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization.